Orchid Pharma gets ANDA approval for Aripiprazole Orally-Disintegrating Table
From USFDA
Orchid Pharma has received ANDA approval from USFDA for Aripiprazole Orally-Disintegrating Tablets USP, 10 mg and 15 mg. The drug is indicated for treatment symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content